Vaccinex annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
Vaccinex Operating Expenses Growth & History (VCNX)
Vaccinex's operating expenses was $19.3M for fiscal 2024.
View full Vaccinex company overviewVaccinex annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $19.3M | −$4.1M | −17.56% |
| 2023 | 2023-12-31 | $23.5M | $3.3M | +16.22% |
| 2022 | 2022-12-31 | $20.2M | −$3.2M | −13.72% |
| 2021 | 2021-12-31 | $23.4M | −$5.6M | −19.22% |
| 2020 | 2020-12-31 | $29.0M | −$3.6M | −11.01% |
| 2019 | 2019-12-31 | $32.5M | $4.5M | +16.19% |
| 2018 | 2018-12-31 | $28.0M | $6.8M | +32.14% |
| 2017 | 2017-12-31 | $21.2M | — | — |
Vaccinex quarterly operating expenses
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $3.6M | −$1.4M | −27.83% |
| Q3 2024 | 2024-09-30 | $4.6M | −$1.3M | −21.35% |
| Q2 2024 | 2024-06-30 | $6.0M | −$1.1M | −15.87% |
| Q1 2024 | 2024-03-31 | $5.2M | −$358,000 | −6.47% |
| Q4 2023 | 2023-12-31 | $5.0M | — | — |
| Q3 2023 | 2023-09-30 | $5.9M | $1.0M | +20.90% |
| Q2 2023 | 2023-06-30 | $7.1M | — | — |
| Q1 2023 | 2023-03-31 | $5.5M | — | — |
| Q3 2022 | 2022-09-30 | $4.8M | −$271,000 | −5.30% |
| Q4 2021 | 2021-12-31 | $5.5M | — | — |
| Q3 2021 | 2021-09-30 | $5.1M | −$4.1M | −44.47% |
| Q2 2021 | 2021-06-30 | $5.7M | — | — |
| Q1 2021 | 2021-03-31 | $7.1M | — | — |
| Q3 2020 | 2020-09-30 | $9.2M | $1.1M | +13.93% |
| Q4 2019 | 2019-12-31 | $6.3M | −$2.4M | −27.60% |
| Q3 2019 | 2019-09-30 | $8.1M | $1.4M | +21.50% |
| Q2 2019 | 2019-06-30 | $8.9M | $2.2M | +32.92% |
| Q1 2019 | 2019-03-31 | $9.2M | $3.3M | +56.11% |
| Q4 2018 | 2018-12-31 | $8.8M | — | — |
| Q3 2018 | 2018-09-30 | $6.7M | — | — |
| Q2 2018 | 2018-06-30 | $6.7M | — | — |
| Q1 2018 | 2018-03-31 | $5.9M | — | — |
Vaccinex operating expenses trends
Over the last five fiscal years, Vaccinex's operating expenses decreased from $32.5M to $19.3M, a change of −$13.2M. The latest reported quarter, Q4 2024, shows $3.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗